Overview


According to FutureWise analysis the market for diabetic eye disease devices is expected to reach US$ 12.19 billion by 2031 at a CAGR of 13.90%.

Diabetic eye disease is a complex condition that affects the eyes and is most commonly caused by diabetes. The blood vessels of tissues behind the eye are damaged in this condition. This condition has no symptoms at first, but it eventually leads to blindness. People with type 1 or type 2 diabetes are more likely to fall into this category. The chance of getting this retinal condition increases rapidly if blood sugar levels are not controlled. Diabetic eye disease is a disorder in which both eyes are affected. As time goes on, a variety of symptoms emerge, including fluctuating vision, floaters in vision, decreased colour vision, empty spaces in vision, and finally vision loss. Diabetic eye disease devices are medical gadgets that are used to treat and diagnose diabetic renal problems. Diabetic retinopathy, diabetic macular edoema, cataract, and glaucoma are the most prevalent diabetic eye illnesses. If not treated promptly, these disorders can result in total blindness. The diabetic eye disease devices market is rising due to an increase in the prevalence of diabetic eye illnesses due to increased smoking addiction, eye injury, hormone replacement therapy, and diseases such as diabetes, hypertension, and obesity. Furthermore, the market is expected to develop due to an increase in the number of geriatrics suffering from diabetic eye disease.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Diabetic Eye Disease Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Diabetic Eye Disease Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Novartis AG
  • Johnson and Johnson
  • Aaren Scientific Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Essilor International S.A.
  • Alcon Inc.
  • Nidek Co., Ltd.
  • STAAR Surgical Company
  • Actavis plc.
  • CooperVision AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Devices

  • Surgery
    • Cataract Surgery Devices
      • Intra Ocular Lens (IOL)
        • Monofocal
        • Multifocal
        • Toric
        • Accomodating
      • Ophthalmic Viscoelastic Devices (OVD)
        • Cohesive
        • Dispersive
      • Phacoemulsification Devices
    • Glaucoma Surgery Devices
      • Glaucoma Drainage Devices
      • Glaucoma Lasers
      • Stents and Implants
      • Systems
    • Refractive Surgery Devices
    • Microkeratome
    • Vitreo Retinal Surgery Devices
      • Vitrectomy Machines
      • Photocoagulation Lasers
    • Ophthalmic Lasers
      • Excimer Laser
      • Femtosecond Laser
      • YAG Laser
      • Glaucoma Lasers
      • Photocoagulation Lasers
  • Ophthalmic Diagnostic and Monitoring Equipment
    • Optical Coherence Tomographers (OCT Scanners)
    • Fundus Cameras
      • Non-Mydriatic
      • Mydriatic
      • Others
    • Slit Lamps
    • Visual Field Analyzers/Perimeters
    • Wavefront Aberrometers
    • Ophthalmic Ultrasound Imaging Systems
    • Ophthalmoscopes
    • Tonometers
    • Autorefractors/Phoropters
    • Keratometers
    • Corneal Topographers
    • Retinoscope
    • Pachymeter
    • Specular Microscope
    • Biometers
    • Optotype Projectors
    • Dioptometers
  • Vision Care
    • Contact Lens
    • Spectacles

By Disease

  • Diabetic Retinopathy
  • Diabetic Macular Edema (DME)
  • Cataract
  • Glaucoma
  • Others

By End User

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Diabetic Eye Disease Devices Market By Devices, By Disease, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Diabetic Eye Disease Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Diabetic Eye Disease Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Diabetic Eye Disease Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Diabetic Eye Disease Devices Market, By Devices Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgery
         1.1. Cataract Surgery Devices
          1.1.1. Intra Ocular Lens (IOL)
           1.1.1.1. Monofocal
           1.1.1.2. Multifocal
           1.1.1.3. Toric
           1.1.1.4. Accomodating
          1.1.2. Ophthalmic Viscoelastic Devices (OVD)
           1.1.2.1. Cohesive
           1.1.2.2. Dispersive
          1.1.3. Phacoemulsification Devices
         1.2. Glaucoma Surgery Devices
          1.2.1. Glaucoma Drainage Devices
          1.2.2. Glaucoma Lasers
          1.2.3. Stents and Implants
          1.2.4. Systems
         1.3. Refractive Surgery Devices
         1.4. Microkeratome
         1.5. Vitreo Retinal Surgery Devices
          1.5.1. Vitrectomy Machines
          1.5.2. Photocoagulation Lasers
         1.6. Ophthalmic Lasers
          1.6.1. Excimer Laser
          1.6.2. Femtosecond Laser
          1.6.3. YAG Laser
          1.6.4. Glaucoma Lasers
          1.6.5. Photocoagulation Lasers
        2. Ophthalmic Diagnostic and Monitoring Equipment
         2.1. Optical Coherence Tomographers (OCT Scanners)
         2.2. Fundus Cameras
          2.2.1. Non-Mydriatic
          2.2.2. Mydriatic
          2.2.3. Others
         2.3. Slit Lamps
         2.4. Visual Field Analyzers/Perimeters
         2.5. Wavefront Aberrometers
         2.6. Ophthalmic Ultrasound Imaging Systems
         2.7. Ophthalmoscopes
         2.8. Tonometers
         2.9. Autorefractors/Phoropters
         2.10.Keratometers
         2.11.Corneal Topographers
         2.12.Retinoscope
         2.13.Pachymeter
         2.14.Specular Microscope
         2.15.Biometers
         2.16.Optotype Projectors
         2.17.Dioptometers
        3. Vision Care
         3.1. Contact Lens
         3.2. Spectacles

  • 8.   Diabetic Eye Disease Devices Market, By Disease Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diabetic Retinopathy
        2. Diabetic Macular Edema (DME)
        3. Cataract
        4. Glaucoma
        5. Others

  • 9.   Diabetic Eye Disease Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ophthalmic Clinics
        3. Others

  • 10.   North America Diabetic Eye Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Diabetic Eye Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Diabetic Eye Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Diabetic Eye Disease Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novartis AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Johnson and Johnson
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Aaren Scientific Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Valeant Pharmaceuticals International, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Essilor International S.A.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Alcon Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nidek Co., Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. STAAR Surgical Company
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Actavis plc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. CooperVision AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients